Correlation Between 90041LAF2 and Cyclo Therapeutics

Can any of the company-specific risk be diversified away by investing in both 90041LAF2 and Cyclo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 90041LAF2 and Cyclo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between US90041LAF22 and Cyclo Therapeutics, you can compare the effects of market volatilities on 90041LAF2 and Cyclo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 90041LAF2 with a short position of Cyclo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 90041LAF2 and Cyclo Therapeutics.

Diversification Opportunities for 90041LAF2 and Cyclo Therapeutics

0.03

Correlation Coefficient

90041LAF2  Cyclo Therapeutics

Significant diversification

The 3 months correlation between 90041LAF2 and Cyclo is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding US90041LAF22 and Cyclo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclo Therapeutics and 90041LAF2 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US90041LAF22 are associated (or correlated) with Cyclo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclo Therapeutics has no effect on the direction of 90041LAF2 i.e., 90041LAF2 and Cyclo Therapeutics go up and down completely randomly.

Pair Corralation between 90041LAF2 and Cyclo Therapeutics

Assuming the 90 days trading horizon US90041LAF22 is expected to under-perform the Cyclo Therapeutics. But the bond apears to be less risky and, when comparing its historical volatility, US90041LAF22 is 23.09 times less risky than Cyclo Therapeutics. The bond trades about -0.28 of its potential returns per unit of risk. The Cyclo Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  61.00  in Cyclo Therapeutics on October 7, 2024 and sell it today you would earn a total of  5.00  from holding Cyclo Therapeutics or generate 8.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	55.0%
Values	Daily Returns

US90041LAF22  vs.  Cyclo Therapeutics

US90041LAF22

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days US90041LAF22 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 90041LAF2 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Cyclo Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cyclo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Cyclo Therapeutics is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with 90041LAF2 and Cyclo Therapeutics

The main advantage of trading using opposite 90041LAF2 and Cyclo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 90041LAF2 position performs unexpectedly, Cyclo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclo Therapeutics will offset losses from the drop in Cyclo Therapeutics' long position.

The idea behind US90041LAF22 and Cyclo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.